Fig. 5.
G-CSF levels are increased by the selective activation of mPFC to NAc projections. a Experimental design of projection-specific DREADD stimulation. Mice were injected with a retrograde traveling CAV2-Cre virus in the NAc and a Cre-dependent hM3Dq-DREADD virus in either the mPFC or the VTA to allow for the specific stimulation of either mPFC to NAc or VTA to NAc. b Csf3 (G-CSF) mRNA levels in the NAc were increased after mPFC to NAc stimulation (one-way ANOVA; F(2,12) = 13.4, p = 0.0009, Sidak post-hoc: p = 0.0037 vs control). c Csf3r (G-CSFR) mRNA levels in the NAc were increased only after mPFC to NAc stimulation (F(2,12) = 8.14, p = 0.0058, p = 0.0093 vs control). d Peripheral G-CSF serum levels were not affected by stimulation (F(2,12) = 1.82, p = 0.20). e Mice were injected i.p. for 7 days with cocaine methiodide (CocMet), a cocaine analog that does not cross the blood brain barrier, to assess the effects of peripheral cocaine on G-CSF. Cocaine methiodide chronic treatment had no effect on f Csf3 (G-CSF) mRNA levels in the NAc (two-tailed Student’s t-test; t (12) = 0.772, p = 0.45), g Csf3r (G-CSFR) mRNA levels in the NAc (t (12) = 1.11, p = 0.29), or h G-CSF serum levels (t (12) = 0.631, p = 0.54). Data represented as mean ± s.e.m. (**p < 0.01 for Sidak post-hoc tests)